# Key Diagnostic & Therapeutic Technologies for Severe Acute High Altitude Disease (SAHAD): Integration and Application

> **NCT07639931** · NA · NOT_YET_RECRUITING · sponsor: **Tibet Autonomous Region People's Hospital** · enrollment: 3035 (estimated)

## Conditions studied

- Severe High Altitude Pulmonary Edema
- Severe High Altitude Cerebral Edema

## Interventions

- **DEVICE:** Multicenter study of HAPE：CPAP or BiPAP Group
- **DRUG:** Multicenter study of HAPE group：NO Group
- **OTHER:** Protocol for Proteomics and Peptidomics Study of HAPE：Case Group

## Key facts

- **NCT ID:** NCT07639931
- **Lead sponsor:** Tibet Autonomous Region People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-12-20
- **Final completion:** 2028-12-31
- **Target enrollment:** 3035 (ESTIMATED)
- **Last updated:** 2026-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07639931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07639931, "Key Diagnostic & Therapeutic Technologies for Severe Acute High Altitude Disease (SAHAD): Integration and Application". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07639931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*